The Royal Wolverhampton NHS Trust (RWT) will work together with British healthtech company Medopad as its official remote patient management solution to improve patient outcomes, adherence and operational gains across primary, secondary and community care.
Medopad’s remote patient management platform for RWT will launch this Spring with projects in cardiology, hypertension, diabetes and many other areas. This will be the first deployment of Medopad in a primary care setting and will be part of a population health initiative to help patients who are diagnosed with hypertension in better managing their condition.
Medopad’s configurable patient-facing mobile app supports individuals living with chronic conditions and rare diseases. Medopad’s platform encourages improved self-management and treatment plan adherence and provides tailored educational content. It also shares valuable remote patient data with patients’ clinicians for improved decision making.
Chief executive of The Royal Wolverhampton NHS Trust, David Loughton CBE, said: “We have been amongst the leading trusts in the country for integrating care across the system and I am delighted that we will be the first NHS Trust in the country that will trial state of the art remote patient monitoring systems across primary, secondary and community care settings.
“We have chosen to work with Medopad as they have excellent links with world class healthcare providers, technology companies and health research bodies and they share our passion for innovation.
"We know that workforce is the greatest challenge facing the NHS and we have to find new and innovative ways to support our hardworking clinicians to improve the experience of delivering care by supporting clinically led innovation. This collaboration with Medopad will enable our doctors and nurses to proactively, and in real-time, monitor patients in their own home and help us in our mission to provide care that is both personalised and timely.”
Sultan Mahmud, director of integration at The Royal Wolverhampton NHS Trust, added: “This opportunity with Medopad allows us to put the patient in the driving seat by using real time information about their health. It is a really helpful platform for patients and clinicians to work together as a team and manage long term conditions differently.”
Dan Vahdat, CEO and funder of Medopad, said: “Medopad and the Royal Wolverhampton NHS Trust share the same vision; to improve quality of care for patients. The Royal Wolverhampton NHS Trust has one of the most forward-thinking teams in healthcare with its integration strategy designed to better serve its community by creating an integrated ecosystem for patient care. By providing a better link between consultants and patients beyond the care setting, we can improve patient, clinical and operational outcomes for the West Midlands region and ultimately create predictive capabilities that will improve health outcomes in the future.”
